Cystic fibrosis transmembrane conductance regulator (CFTR)-targeted therapeutics for cystic fibrosis
Treatment of the common life-limiting genetic disease cystic fibrosis (CF) has been transformed by small molecule therapeutics that target the root cause of the disease, pathogenic variants in the ATP-binding cassette transporter cystic fibrosis transmembrane conductance regulator (CFTR). Here, we s...
| Autores principales: | , , , , , , , , , |
|---|---|
| Otros Autores: | |
| Formato: | Book section |
| Lenguaje: | English |
| Publicado: |
Springer
2024
|